Nippon Boehringer Ingelheim Co Ltd.

Industry / private company


Location: Kobe, Japan (JP) JP

ISNI: 0000000446781308

ROR: https://ror.org/02r1d7x68

Show on Map:

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Pharmacokinetic-Interactions of BI 425809, a Novel Glycine Transporter 1 Inhibitor, with Cytochrome P450 and P-Glycoprotein Substrates: Findings from in Vitro Analyses and an Open-Label, Single-Sequence Phase i Study (2023) Desch M, Schlecker C, Hohl K, Liesenfeld KH, Chan T, Müller F, Wunderlich G, et al. Journal article Organ protection by SGLT2 inhibitors: role of metabolic energy and water conservation (2020) Marton A, Kaneko T, Kovalik JP, Yasui A, Nishiyama A, Kitada K, Titze J Journal article, Review article Validation of a Drug Transporter Probe Cocktail Using the Prototypical Inhibitors Rifampin, Probenecid, Verapamil, and Cimetidine (2020) Wiebe ST, Giessmann T, Hohl K, Schmidt-Gerets S, Hauel E, Jambrecina A, Bader K, et al. Journal article A Comprehensive Whole-Body Physiologically Based Pharmacokinetic Drug–Drug–Gene Interaction Model of Metformin and Cimetidine in Healthy Adults and Renally Impaired Individuals (2020) Hanke N, Türk D, Selzer D, Ishiguro N, Ebner T, Wiebe S, Müller F, et al. Journal article Optimization of a drug transporter probe cocktail: potential screening tool for transporter-mediated drug-drug interactions (2018) Stopfer P, Giessmann T, Hohl K, Hutzel S, Schmidt S, Gansser D, Ishiguro N, et al. Journal article